Peginterferon test for inactive chronic hepatitis B
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial studies whether pegylated interferon can help people with inactive chronic hepatitis B stay stable or improve outcomes. You may qualify if your virus levels and liver blood tests are currently low and you’ve never used antiviral treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 60 years old
- You’ve had hepatitis B surface antigen (HBsAg) positive for more than 6 months
- Your hepatitis B “e” blood tests are in the inactive pattern (HBeAg negative and anti-HBe positive)
- Your HBV DNA viral load is under 2000 IU/mL and your ALT and/or AST liver enzymes are normal
- You have never taken hepatitis B antiviral medicines (including interferon or similar drugs) before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sequence of pegylated interferon (PEG-IFN) shots for people with chronic hepatitis B who have already had a significant drop in their virus levels after taking a newer type of RNA-targeting medicine. The goal is to see if this approach can help clear the virus even further.
This trial tests if peginterferon alfa-2b can help children with chronic hepatitis B achieve a functional cure. If your child has had hepatitis B for a while and still has the virus in their blood, this study might be an option.
This Phase 2 trial studies an injection (HRS-5635), either alone or with other medicines, to see if it is safe and helps keep chronic hepatitis B under control. It is for people who are already on standard hepatitis B antivirals and have low or undetectable viral levels.
This study tests whether combining peginterferon alpha-2b with a nucleoside analog can lower liver cancer risk in people with chronic hepatitis B who have a family history of liver cancer. It compares the combination therapy to nucleoside analog alone.
This study tests whether a long-acting interferon medication can help people with chronic hepatitis B who have already received interferon treatment clear the hepatitis B virus more completely. It's designed for patients whose virus levels dropped significantly during their first treatment but haven't gone away.
This trial tests a medicine called peg-interferon for people who have both chronic hepatitis B and fatty liver. It aims to see if the treatment is safe and effective in helping your body fight the hepatitis B virus.
Hear when a new Hepatitis B, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.